Enliven Therapeutics
ELVN
#5204
Rank
โ‚ฌ1.32 B
Marketcap
22,34ย โ‚ฌ
Share price
11.83%
Change (1 day)
5.28%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ89.85 Million a decrease over its 2023 earnings that were of -โ‚ฌ71.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion12.17%
2024 -โ‚ฌ89.85 Million25.17%
2023 -โ‚ฌ71.78 Million115.33%
2022 -โ‚ฌ33.34 Million